Neurobiology of Disease (Feb 2007)

Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment

  • Cornelia Franke,
  • Michael Nöldner,
  • Reham Abdel-Kader,
  • Leslie N. Johnson-Anuna,
  • W. Gibson Wood,
  • Walter E. Müller,
  • Gunter P. Eckert

Journal volume & issue
Vol. 25, no. 2
pp. 438 – 445

Abstract

Read online

The present study determined if chronic simvastatin administration in vivo would provide neuroprotection in brain cells isolated from guinea pigs after challenge with the Bcl-2 inhibitor HA 14-1 or the NO donor sodium nitroprusside (SNP). Bcl-2 levels were significantly increased in brains of simvastatin-treated guinea pigs while levels of the pro-apoptotic protein Bax were significantly reduced. The ratio of Bax/Bcl-2, being a critical factor of the apoptotic state of cells, was significantly reduced in simvastatin-treated animals. Cholesterol levels in the brain remained unchanged in the simvastatin group. Brain cells isolated from simvastatin-treated guinea pigs were significantly less vulnerable to mitochondrial dysfunction and caspase-activation. These results provide new insight into potential mechanisms for the protective actions of statins within the CNS where programmed cell death has been implicated.

Keywords